At the end of the latest market close, PAVmed Inc. (PAVM) was valued at $5.79. In that particular session, Stock kicked-off at the price of $6.31 while reaching the peak value of $6.36 and lowest value recorded on the day was $5.73. The stock current value is $5.84.
Recently in News on June 10, 2021, PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test. PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that its major subsidiary, Lucid Diagnostics Inc. (“Lucid”), has completed European IVDD CE Mark certification of its EsoGuard® Esophageal DNA Test (“EsoGuard”). You can read further details here
PAVmed Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.59 on 04/07/21, with the lowest value was $1.96 for the same time period, recorded on 01/15/21.
PAVmed Inc. (PAVM) full year performance was 171.83%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, PAVmed Inc. shares are logging -11.38% during the 52-week period from high price, and 258.28% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.63 and $6.59.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 804126 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the PAVmed Inc. (PAVM) recorded performance in the market was 173.11%, having the revenues showcasing 51.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 468.06M, as it employees total of 25 workers.
Market experts do have their say about PAVmed Inc. (PAVM)
During the last month, 2 analysts gave the PAVmed Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.24, with a change in the price was noted +3.79. In a similar fashion, PAVmed Inc. posted a movement of +188.56% for the period of last 100 days, recording 4,030,735 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PAVM is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of PAVmed Inc. (PAVM)
Raw Stochastic average of PAVmed Inc. in the period of last 50 days is set at 71.58%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 72.23%. In the last 20 days, the company’s Stochastic %K was 77.92% and its Stochastic %D was recorded 85.92%.
Bearing in mind the latest performance of PAVmed Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 173.11%. Additionally, trading for the stock in the period of the last six months notably improved by 193.91%, alongside a boost of 171.83% for the period of the last 12 months. The shares increased approximately by 4.51% in the 7-day charts and went down by 43.67% in the period of the last 30 days. Common stock shares were driven by 51.57% during last recorded quarter.